Table 1.
Patient characteristics and clinical management (n=224).
| n (%) | |
|---|---|
| Age in years, median (IQR) | 12 (8, 15) |
| 2—4 years old, n (%)1 | 6 (2.7) |
| 2–5 years old, n (%)1 | 12 (5.4) |
| 2–6 years old, n (%)1 | 26 (11.6) |
| Female, n (%) | 118 (52.7) |
| Race/ethnicity, n (%) | |
| Hispanic or Latino | 170 (75.9) |
| Black or African-American | 21 (9.4) |
| White | 12 (5.4) |
| Asian | 2 (0.8) |
| More than one | 1 (0.4) |
| Don’t know | 3 (1.3) |
| Missing | 15 (6.7) |
| Primary language, n (%) | |
| English | 147 (65.6) |
| Spanish | 68 (30.4) |
| Missing | 9 (4) |
| Patient took an analgesic(s) for headache within 12 hours of presenting to ED, n (%)2 | 142 (63.4) |
| Non-steroidal anti-inflammatory drug | 91 (40.6) |
| Acetaminophen | 60 (26.8) |
| Triptan (e.g. sumatriptan) | 1 (0.4) |
| Metaclopramide or compazine | 0 |
| Other | 14 (6.3) |
| Received neuroimaging in emergency department, n (%) | |
| Any neuroimaging | 74 (33) |
| CT | 23 (10.3) |
| MRI | 51 (22.7) |
| Disposition, n (%) | |
| Home | 216 (96.4) |
| Admit, general inpatient service | 7(3.1) |
| Admit, PICU | 1 (0.4) |
| Received outpatient neuroimaging, n (%)3 | |
| No outpatient neuroimaging | 102 (81.6) |
| Any neuroimaging | 23 (18.4) |
| CT | 4 (3.2) |
| MRI | 17 (13.6) |
| Both CT and MRI | 1 (0.8) |
| Unsure of neuroimaging type | 1 (0.8) |
1
These age groupings were chosen to show the number of children that would be considered at higher risk of emergent intracranial abnormality due to young age, based on different age cutoffs that have been described in the literature.
2
Patients may have taken more than one type of analgesic.
3
Only includes patients who did not receive neuroimaging in the ED and completed follow up (n=125).
IQR: interquartile range; CT: computed tomography; MRI: magnetic resonance imaging; PICU: pediatric intensive care unit.